STERIS plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Daniel A. Carestio
- Full Time Employees
- 18,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 70 Sir John Rogerson's Quay Dublin United States of America D02 R296
- IPO Date
- Jun 1, 1992
- CIK
- 0001757898
- Website
- steris.com
- Similar Companies
- Business
- STERIS plc (NYSE: STE), headquartered in Dublin, Ireland, with U.S. operational headquarters in Mentor, Ohio, is a leading global provider of infection prevention, contamination control, and procedural support products and services to healthcare, pharmaceutical, medical device, life sciences, and industrial customers in more than 100 countries. Founded in 1985 as Innovative Medical Technologies, the company offers capital equipment including steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, automated washer/disinfectors, surgical tables, lights, booms, operating room integration systems, and automated endoscope reprocessors; consumables such as detergents, disinfectants, endoscopy accessories, barrier products, sterility assurance indicators, biological and chemical monitoring tools, sterilization pouches, and surgical instruments including V. Mueller, Snowden-Pencer, and Genesis brands; and services encompassing equipment installation and maintenance, instrument and scope repair, outsourced reprocessing, laboratory testing, contract sterilization via gamma irradiation, electron beam, ethylene oxide, and X-ray technologies, and gastrointestinal support solutions. STERIS operates through segments including Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies, targeting hospitals, surgery centers, medical device and pharmaceutical manufacturers, research facilities, and bioprocessing clients with a workforce exceeding 18,000 associates. Recent developments include the 2023 acquisition of Becton, Dickinson and Company's surgical instrumentation, laparoscopic, and sterilization container assets to expand healthcare offerings; facility expansions such as the 2025 openings of an ethylene oxide processing plant in Batu Kawan, Malaysia, and an X-ray processing addition in Suzhou, China; a 2024 business segment restructuring; and fiscal 2025 guidance projecting 8-9% revenue growth driven by consumables, services, and bioprocessing demand.
Here's Why Steris (STE) is a Strong Growth Stock
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS Q4 Earnings Call Highlights
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS plc (STE) Q4 2026 Earnings Call Transcript
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Steris forecasts 2027 profit above estimates, banks on procedure-driven demand
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
STERIS Appoints Pierre Boulud to Board of Directors
STERIS Announces Dividend of $0.63 per share
STERIS' Q4 Earnings on Deck: What's in Store for the Stock?
Critical Contrast: Bluejay Diagnostics (NASDAQ:BJDX) & STERIS (NYSE:STE)
STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
Rep. April McClain Delaney Buys Shares of Somnigroup International Inc. (NYSE:SGI)
Rep. April McClain Delaney Buys Packaging Corporation of America (NYSE:PKG) Shares
Tractor Supply (NASDAQ:TSCO) Stock Acquired Rep. April McClain Delaney
Is This the Right Time to Hold STERIS Stock in Your Portfolio?
Aberdeen Group plc Buys 20,097 Shares of STERIS plc $STE
Assenagon Asset Management S.A. Cuts Holdings in STERIS plc $STE
Virtus SGA International Growth Q4 2025 Portfolio Activity And Performance